Approach to the patient with pulmonary-renal syndrome caused by antithyroid drug-induced ANCA-associated vasculitis
10.3760/cma.j.issn.1000-6699.2014.02.024
- VernacularTitle:抗甲状腺功能亢进症药物引起的以肺肾综合征为表现的ANCA相关性血管炎的临诊应对
- Author:
Junhui XIE
;
Yebing HE
;
Fuqiong CHEN
;
Xiaofeng HE
;
Ying YAO
- Publication Type:Journal Article
- Keywords:
Antithyroid drugs;
Antineutrophil cytoplasmic antibody-associated vasculitis;
Pulmonary-renal syndrome
- From:
Chinese Journal of Endocrinology and Metabolism
2014;30(2):171-173
- CountryChina
- Language:Chinese
-
Abstract:
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) refers to the groups of potentially life-threatening autoimmune disease.Antithyroid drug is one of the causes.Usually the involved organs are skin,kidney,and (or) lung.Early diagnosis and treatment of AAV is essential.Timely cessation of antithyroid drugs is the first step.If necessary,glucocorticoids and (or) immunosuppressive agents should be used to delay the progression of the disease.